There are more than 1.2 million people living with Parkinson's in Europe today and this number is forecast to double by 2030. The annual European cost of the disease is estimated at €13.9 billion, and as our population continues to live longer, this cost will continue to rise dramatically – especially in the later stages of the disease where the impact is greatest on people with Parkinson's, their families and carers, and society as a whole.
Please sign our pledge to help us:
Increase funding for research
Establish best practice in the management of Parkinson's disease
Expand the influence of national Parkinson's disease organisations
Prioritise neurodegenerative disorders with European policymakers.
I support the EPDA in its efforts to work with european policymakers towards:
Maintaining and increasing funding for Parkinson’s disease research under the EU Horizon 2020 framework programme.
Establishing best practice in the management of Parkinson’s disease across Europe.
Expanding the influence of national patient organisations to help people with Parkinson’s disease become more involved in their own treatment.
Ensuring that neurodegenerative diseases become an EU healthcare policy priority